75N93025F00001↗
Sri International received this contract from National Institutes of Health Niaid, National Institutes of Health: $5.13M obligated so far for health r&d services; health care services; applied research. It runs to 2027-07-20.
Key facts · data as of Oct 23, 2026
- Recipient
- Sri International
- Awarding agency
- National Institutes of Health (Department of Health and Human Services)
- Contracting office
- National Institutes of Health Niaid (75N930)
- Obligated to date
- $5.13M
- Potential value
- $5.13M
- Ends
- 2027-07-20
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 23, 2026.
Cite this page: SpendQuery, Award 75N93025F00001, data as of Oct 23, 2026, https://spendquery.com/award?id=CONT_AWD_75N93025F00001_7529_75N93020D00011_7529
Sri International: all federal awards · Department of Health and Human Services: spending · National Institutes of Health Niaid: what it buys · The follow-on: recompete brief
NON-CLINICAL STUDIES IN SUPPORT OF IND/NDA/BLA SUBMISSIONS
Up for re-bid: ends 2027-07-20. Recompete brief → · 2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases ↗
What it is
- Product or service
- Health R&D Services; Health Care Services; Applied Research (PSC AN12)
- Industry
- Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) (NAICS 541715)
- Contracting office
- National Institutes of Health Niaid (75N930)
- Competition
- Full and open competition
- Pricing
- Cost plus fixed fee
- How it was bought
- Single-award IDIQ · under 75N93020D00011
- Where the work is
- San Mateo, CA · district CA-16
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
2 subawards totaling $195.2K (3.8% of what was obligated), as Sri International reported them. Primes report subawards of $30,000 or more; smaller ones and unreported ones aren't here.
| Subcontractor | Amount | Subawards | Where | First | Last |
|---|---|---|---|---|---|
| Dow Development Laboratories, LLC | $126.0K | 1 | CA | 2026-04-15 | 2026-04-15 |
| Discovery Life Sciences, LLC | $69.2K | 1 | AL | 2026-04-10 | 2026-04-10 |
The largest single subawards
| Date | To | Amount | For |
|---|---|---|---|
| 2026-04-15 | Dow Development Laboratories, LLC | $126.0K | NON-GLP DEVELOPMENT OF NONOPARTICLE PRODUCT |
| 2026-04-10 | Discovery Life Sciences, LLC | $69.2K | TRANSPORTER STUDY |
Every action
2 actions since 2025-07-25. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-05-11 | P00001 | Change order | $1.51M | NON-CLINICAL STUDIES IN SUPPORT OF IND/NDA/BLA SUBMISSIONS |
| 2025-07-25 | 0 | $3.63M | NON-CLINICAL STUDIES IN SUPPORT OF IND/NDA/BLA SUBMISSIONS |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-23). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗